Affinity Asset Advisors, LLC
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| STATE STR SPDR S&P 500 ETF T(SPY)(Put) | 0 | 200,000 | +200,000 | 0 | 130,068,000 | — | +130,068,000 |
| ERASCA INC(ERAS) | 3,900,000 | 5,350,000 | +1,450,000 | 14,508,000 | 86,563,000 | 5.08% | +72,055,000 |
| XENON PHARMACEUTICALS INC(XENE) | 1,250,000 | 1,675,000 | +425,000 | 56,025,000 | 97,401,250 | 5.71% | +41,376,250 |
| ROIVANT SCIENCES LTD(ROIV) | 1,700,000 | 2,800,000 | +1,100,000 | 36,890,000 | 77,560,000 | 4.55% | +40,670,000 |
| MODERNA INC(MRNA)(Call) | 0 | 800,000 | +800,000 | 0 | 40,640,000 | — | +40,640,000 |
| CENTESSA PHARMACEUTICALS PLC | 600,552 | 1,400,000 | +799,448 | 15,019,806 | 55,608,000 | 3.26% | +40,588,194 |
| ANAPTYSBIO INC | 444,692 | 940,000 | +495,308 | 21,558,668 | 52,132,400 | 3.06% | +30,573,732 |
| DIANTHUS THERAPEUTICS INC(DNTH) | 115,000 | 350,000 | +235,000 | 4,739,150 | 29,372,000 | 1.72% | +24,632,850 |
| ENLIVEN THERAPEUTICS INC | 0 | 586,904 | +586,904 | 0 | 23,006,637 | 1.35% | +23,006,637 |
| ALKERMES PLC(ALKS) | 1,000,000 | 1,350,000 | +350,000 | 27,980,000 | 47,736,000 | 2.80% | +19,756,000 |
| BRISTOL-MYERS SQUIBB CO(BMY)(Call) | 0 | 300,000 | +300,000 | 0 | 18,195,000 | — | +18,195,000 |
| SUTRO BIOPHARMA INC | 748,382 | 1,069,519 | +321,137 | 8,658,780 | 26,641,718 | 1.56% | +17,982,938 |
| SPYRE THERAPEUTICS INC(SYRE) | 1,432,591 | 1,279,134 | -153,457 | 46,931,681 | 64,519,519 | 3.78% | +17,587,838 |
| COGENT BIOSCIENCES INC(COGT) | 350,000 | 750,000 | +400,000 | 12,432,000 | 28,867,500 | 1.69% | +16,435,500 |
| ASCENDIS PHARMA A/S(ASND) | 30,000 | 95,000 | +65,000 | 6,397,200 | 21,729,350 | 1.27% | +15,332,150 |
| APOGEE THERAPEUTICS INC(APGE) | 1,234,926 | 1,284,926 | +50,000 | 93,212,214 | 108,152,221 | 6.34% | +14,940,007 |
| HELIX ACQUISITION CORP III | 0 | 1,250,000 | +1,250,000 | 0 | 12,700,000 | 0.74% | +12,700,000 |
| PERSPECTIVE THERAPEUTICS INC | 300,000 | 3,164,582 | +2,864,582 | 825,000 | 13,196,307 | 0.77% | +12,371,307 |
| OVID THERAPEUTICS INC | 7,150,000 | 10,636,318 | +3,486,318 | 11,654,500 | 23,612,626 | 1.38% | +11,958,126 |
| DAMORA THERAPEUTICS INC(DMRA) | 0 | 450,000 | +450,000 | 0 | 11,655,000 | 0.68% | +11,655,000 |
| ALTO NEUROSCIENCE INC(ANRO) | 0 | 500,000 | +500,000 | 0 | 11,240,000 | 0.66% | +11,240,000 |
| MADRIGAL PHARMACEUTICALS INC(MDGL) | 31,131 | 55,000 | +23,869 | 18,128,827 | 28,790,850 | 1.69% | +10,662,023 |
| TYRA BIOSCIENCES INC(TYRA) | 0 | 257,512 | +257,512 | 0 | 9,862,710 | 0.58% | +9,862,710 |
| REVOLUTION MEDICINES INC(RVMD)(Put) | 0 | 100,000 | +100,000 | 0 | 9,725,000 | — | +9,725,000 |
| IMMUNITYBIO INC(IBRX)(Put) | 0 | 1,250,000 | +1,250,000 | 0 | 9,587,500 | — | +9,587,500 |
| EUPRAXIA PHARMACEUTICALS INC | 300,000 | 1,589,005 | +1,289,005 | 2,265,000 | 11,504,396 | 0.67% | +9,239,396 |
| KORRO BIO INC | 0 | 706,904 | +706,904 | 0 | 8,002,153 | 0.47% | +8,002,153 |
| ARROWHEAD PHARMACEUTICALS IN(ARWR) | 70,000 | 200,000 | +130,000 | 4,647,300 | 12,540,000 | 0.74% | +7,892,700 |
| ARCELLX INC COMMON STOCK | 523,725 | 362,764 | -160,961 | 34,146,870 | 41,652,562 | 2.44% | +7,505,692 |
| TERNS PHARMACEUTICALS INC | 550,000 | 562,631 | +12,631 | 22,220,000 | 29,661,906 | 1.74% | +7,441,906 |
| COGENT BIOSCIENCES INC(COGT) | 0 | 0 | 0 | 1,175,800 | 8,585,500 | 0.50% | +7,409,700 |
| BELITE BIO INC(BLTE) | 20,000 | 65,000 | +45,000 | 3,199,200 | 10,363,600 | 0.61% | +7,164,400 |
| CRISPR THERAPEUTICS AG(CRSP) | 0 | 150,000 | +150,000 | 0 | 7,135,500 | 0.42% | +7,135,500 |
| SPYGLASS PHARMA INC | 0 | 250,000 | +250,000 | 0 | 6,477,500 | 0.38% | +6,477,500 |
| NOVO-NORDISK A S(NVO)(Call) | 0 | 175,000 | +175,000 | 0 | 6,431,250 | — | +6,431,250 |
| CELLDEX THERAPEUTICS INC NEW(CLDX) | 350,000 | 500,000 | +150,000 | 9,506,000 | 15,860,000 | 0.93% | +6,354,000 |
| ZURA BIO LTD | 1,813,671 | 2,564,303 | +750,632 | 9,503,636 | 15,257,603 | 0.89% | +5,753,967 |
| COMPASS PATHWAYS PLC(CMPS) | 200,000 | 1,108,483 | +908,483 | 1,380,000 | 6,129,911 | 0.36% | +4,749,911 |
| VERADERMICS INC(MANE) | 0 | 70,000 | +70,000 | 0 | 4,420,500 | 0.26% | +4,420,500 |
| GENERATE BIOMEDICINES INC(GENB) | 0 | 350,000 | +350,000 | 0 | 4,375,000 | 0.26% | +4,375,000 |
| DIANTHUS THERAPEUTICS INC(DNTH)(Call) | 0 | 50,000 | +50,000 | 0 | 4,196,000 | — | +4,196,000 |
| CG ONCOLOGY INC(CGON)(Call) | 0 | 60,000 | +60,000 | 0 | 4,060,800 | — | +4,060,800 |
| RELAY THERAPEUTICS INC(RLAY) | 0 | 400,000 | +400,000 | 0 | 3,980,000 | 0.23% | +3,980,000 |
| CELCUITY INC(CELC)(Call) | 0 | 30,000 | +30,000 | 0 | 3,424,200 | — | +3,424,200 |
| PRECISION BIOSCIENCES INC | 0 | 597,946 | +597,946 | 0 | 3,288,703 | 0.19% | +3,288,703 |
| PROTAGONIST THERAPEUTICS INC | 172,125 | 172,125 | 0 | 15,033,398 | 18,141,975 | 1.06% | +3,108,577 |
| SOL-GEL TECHNOLOGIES LTD SHS NEW | 0 | 35,000 | +35,000 | 0 | 2,772,700 | 0.16% | +2,772,700 |
| ANTERIS TECHNOLOGIES GLOBAL | 486,684 | 912,397 | +425,713 | 2,428,553 | 5,063,803 | 0.30% | +2,635,250 |
| EQUILLIUM INC | 0 | 1,226,310 | +1,226,310 | 0 | 2,452,620 | 0.14% | +2,452,620 |
| SAB BIOTHERAPEUTICS INC | 0 | 575,000 | +575,000 | 0 | 2,202,250 | 0.13% | +2,202,250 |
| CORCEPT THERAPEUTICS INC(CORT) | 0 | 50,000 | +50,000 | 0 | 2,015,500 | 0.12% | +2,015,500 |
| IBIO INC | 2,057,200 | 3,107,200 | +1,050,000 | 3,970,396 | 5,903,680 | 0.35% | +1,933,284 |
| REVOLUTION MEDICINES INC(RVMD) | 100,000 | 100,000 | 0 | 7,965,000 | 9,725,000 | 0.57% | +1,760,000 |
| ADLAI NORTYE LTD | 0 | 164,748 | +164,748 | 0 | 1,140,056 | 0.07% | +1,140,056 |
| ALECTOR INC | 0 | 500,000 | +500,000 | 0 | 1,075,000 | 0.06% | +1,075,000 |
| ARRIVENT BIOPHARMA INC(AVBP) | 150,000 | 175,000 | +25,000 | 3,018,000 | 4,037,250 | 0.24% | +1,019,250 |
| ONKURE THERAPEUTICS INC | 0 | 240,963 | +240,963 | 0 | 997,587 | 0.06% | +997,587 |
| AVALO THERAPEUTICS INC(AVTX) | 1,051,054 | 1,340,840 | +289,786 | 19,087,141 | 20,018,741 | 1.17% | +931,600 |
| LENZ THERAPEUTICS INC | 0 | 100,000 | +100,000 | 0 | 915,000 | 0.05% | +915,000 |
| CELCUITY INC(CELC) | 0 | 0 | 0 | 6,515,700 | 7,314,000 | 0.43% | +798,300 |
| MACROGENICS INC | 484,308 | 500,000 | +15,692 | 779,736 | 1,445,000 | 0.08% | +665,264 |
| KEZAR LIFE SCIENCES INC COM NEW | 229,076 | 229,076 | 0 | 1,440,888 | 1,699,744 | 0.10% | +258,856 |
| PRAXIS PRECISION MEDICINES I(PRAX) | 185,000 | 170,000 | -15,000 | 54,526,900 | 54,772,300 | 3.21% | +245,400 |
| ORUKA THERAPEUTICS INC(ORKA) | 802,342 | 499,673 | -302,669 | 24,318,986 | 24,508,961 | 1.44% | +189,975 |
| INSMED INC(INSM) | 450,000 | 480,000 | +30,000 | 78,318,000 | 78,489,600 | 4.60% | +171,600 |
| Q32 BIO INC | 27,777 | 27,777 | 0 | 92,220 | 178,328 | 0.01% | +86,108 |
| X4 PHARMACEUTICALS INC | 145,000 | 145,000 | 0 | 580,000 | 598,850 | 0.04% | +18,850 |
| OAKTREE ACQUISITION CORP III UNIT 10/04/2029 | 250,000 | 250,000 | 0 | 2,652,500 | 2,662,500 | 0.16% | +10,000 |
| ADAGIO MED HLDGS INC | 80,000 | 80,000 | 0 | 83,200 | 92,000 | 0.01% | +8,800 |
| ROCKET PHARMACEUTICALS INC | 75,000 | 75,000 | 0 | 1,823 | 1,178 | 0.00% | -645 |
| CLIMB BIO INC | 1,300,000 | 700,000 | -600,000 | 5,200,000 | 4,795,000 | 0.28% | -405,000 |
| FORTE BIOSCIENCES INC(FBRX)(Call) | 22,400 | 0 | -22,400 | 610,848 | 0 | — | -610,848 |
| PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS | 50,000 | 0 | -50,000 | 651,500 | 0 | — | -651,500 |
| ORCHESTRA BIOMED HLDGS INC | 572,804 | 402,550 | -170,254 | 2,377,137 | 1,710,838 | 0.10% | -666,299 |
| NEWAMSTERDAM PHARMA COMPANY *W EXP 99/99/999 | 245,000 | 245,000 | 0 | 5,635,000 | 4,909,800 | 0.29% | -725,200 |
| CRINETICS PHARMACEUTICALS IN(CRNX) | 75,000 | 75,000 | 0 | 3,491,250 | 2,724,000 | 0.16% | -767,250 |
| FORTE BIOSCIENCES INC(FBRX) | 989,490 | 1,011,890 | +22,400 | 26,983,392 | 26,207,951 | 1.54% | -775,441 |
| REZOLUTE INC | 2,351,144 | 1,547,641 | -803,503 | 5,548,700 | 4,720,305 | 0.28% | -828,395 |
| NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES | 275,000 | 275,000 | 0 | 9,647,000 | 8,802,750 | 0.52% | -844,250 |
| NEXTCURE INC | 247,294 | 241,826 | -5,468 | 3,509,102 | 2,582,702 | 0.15% | -926,400 |
| PROQR THRAPEUTICS N V SHS EURO | 2,454,278 | 2,454,278 | 0 | 4,957,642 | 3,975,930 | 0.23% | -981,712 |
| UNIQURE NV(QURE) | 50,000 | 0 | -50,000 | 1,196,500 | 0 | — | -1,196,500 |
| TEVA PHARMACEUTICAL INDS LTD(TEVA) | 1,400,000 | 1,400,000 | 0 | 43,694,000 | 42,168,000 | 2.47% | -1,526,000 |
| LENZ THERAPEUTICS INC(Put) | 100,000 | 0 | -100,000 | 1,600,000 | 0 | — | -1,600,000 |
| ENGENE HOLDINGS INC COM | 643,370 | 610,370 | -33,000 | 5,809,631 | 4,156,620 | 0.24% | -1,653,011 |
| NUVALENT INC(NUVL) | 322,633 | 300,000 | -22,633 | 32,453,653 | 30,735,000 | 1.80% | -1,718,653 |
| ULTRAGENYX PHARMACEUTICAL IN(RARE) | 75,000 | 0 | -75,000 | 1,725,000 | 0 | — | -1,725,000 |
| GERON CORP(GERN) | 1,500,000 | 0 | -1,500,000 | 1,980,000 | 0 | — | -1,980,000 |
| JADE BIOSCIENCES INC | 714,956 | 639,956 | -75,000 | 11,031,771 | 8,991,382 | 0.53% | -2,040,389 |
| VERRICA PHARMACEUTICALS INC | 707,338 | 707,338 | 0 | 5,877,979 | 3,741,818 | 0.22% | -2,136,161 |
| SAGIMET BIOSCIENCES INC | 1,148,245 | 868,020 | -280,225 | 6,797,610 | 4,535,405 | 0.27% | -2,262,205 |
| ARBUTUS BIOPHARMA CORP(ABUS)(Call) | 521,900 | 0 | -521,900 | 2,510,339 | 0 | — | -2,510,339 |
| TRAVERE THERAPEUTICS INC(TVTX) | 300,000 | 300,000 | 0 | 11,463,000 | 8,913,000 | 0.52% | -2,550,000 |
| IMMUNOVANT INC(IMVT) | 200,000 | 100,000 | -100,000 | 5,084,000 | 2,484,000 | 0.15% | -2,600,000 |
| VERA THERAPEUTICS INC(VERA) | 250,000 | 250,000 | 0 | 12,660,000 | 10,057,500 | 0.59% | -2,602,500 |
| LEXEO THERAPEUTICS INC | 3,200,000 | 5,050,211 | +1,850,211 | 31,776,000 | 28,988,211 | 1.70% | -2,787,789 |
| VIRIDIAN THERAPEUTICS INC(VRDN) | 250,000 | 250,000 | 0 | 7,780,000 | 4,890,000 | 0.29% | -2,890,000 |
| MERSANA THERAPEUTICS INC | 100,000 | 0 | -100,000 | 2,893,000 | 0 | — | -2,893,000 |
| TREVI THERAPEUTICS INC(TRVI) | 2,150,172 | 2,000,172 | -150,000 | 26,920,153 | 23,862,052 | 1.40% | -3,058,101 |
| SAVARA INC(SVRA) | 2,797,153 | 2,512,153 | -285,000 | 16,866,833 | 13,716,355 | 0.80% | -3,150,478 |